Advertisement
U.S. markets closed
  • S&P Futures

    5,304.25
    -4.00 (-0.08%)
     
  • Dow Futures

    40,140.00
    -36.00 (-0.09%)
     
  • Nasdaq Futures

    18,465.00
    -38.75 (-0.21%)
     
  • Russell 2000 Futures

    2,145.20
    +6.80 (+0.32%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0790
    -0.0003 (-0.03%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • Vix

    13.01
    +0.23 (+1.80%)
     
  • GBP/USD

    1.2622
    -0.0000 (-0.00%)
     
  • USD/JPY

    151.3580
    -0.0140 (-0.01%)
     
  • Bitcoin USD

    70,682.05
    +957.04 (+1.37%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,350.19
    +182.12 (+0.45%)
     

Is A Short Squeeze Ahead for Spectrum Pharma (SPPI)?

Many investors appear to be quite bearish Spectrum Pharmaceuticals, Inc. (SPPI) especially if you look at the percentage of the float that is sold short for this stock. Currently, 22.6% of the float is sold short, suggesting an extreme level of bearishness for SPPI.

However, it is worth noting that earnings estimates have actually been moving higher for the company, despite the pessimism. Thanks to these rising estimates, we actually have a Zacks Rank #2 (Buy) on SPPI, so we clearly don’t believe in the negativity surrounding this firm, and are instead looking for shares of SPPI to move higher in the weeks ahead.




SPECTRUM PHARMACEUTICALS INC (SPPI): Free Stock Analysis Report


Zacks Investment Research

Advertisement